Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-11-046310
Filing Date
2011-08-12
Accepted
2011-08-12 08:10:23
Documents
11
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a11-14110_110q.htm 10-Q 1108625
2 EX-31.1 a11-14110_1ex31d1.htm EX-31.1 12543
3 EX-31.2 a11-14110_1ex31d2.htm EX-31.2 12639
4 EX-32.1 a11-14110_1ex32d1.htm EX-32.1 5733
5 EX-32.2 a11-14110_1ex32d2.htm EX-32.2 5403
  Complete submission text file 0001104659-11-046310.txt   4146151

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT irwd-20110630.xml EX-101.INS 562492
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT irwd-20110630.xsd EX-101.SCH 15955
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT irwd-20110630_cal.xml EX-101.CAL 47735
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT irwd-20110630_lab.xml EX-101.LAB 277463
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT irwd-20110630_pre.xml EX-101.PRE 136481
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT irwd-20110630_def.xml EX-101.DEF 108581
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Filer) CIK: 0001446847 (see all company filings)

EIN.: 043404176
Type: 10-Q | Act: 34 | File No.: 001-34620 | Film No.: 111029193
SIC: 2834 Pharmaceutical Preparations